Betnovate

Product description

Betnovate is indicated in therapies where soreness, itchy sensations, swellings, or the rest of discomforting symptoms of skin conditions need to be relieved. This drug affects the human organism via its corticosteroid nature. Its active ingredient is betamethasone, widely applied due to the potent anti-inflammatory capabilities.

Dosage of this medication significantly varies from patient to patient. The skin condition sufferers eligible for treatment should follow individual directions by their doctor or the prescription data specified on the label. This pharmaceutical description provides only the average reference doses of Betnovate. If you have been prescribed a different dose, keep adhering to it until the time established by your doctor or his/her further guidance.

The drug quantities that you take are directly connected to the strength of the medication. Furthermore, the daily number of administrations, the spacing maintained between doses, as well as the overall duration of treatment with the medicine are established to meet the particularities of your current medical issue.

Information on use and dosing

Reference doses for soreness, itchy sensations, and skin swellings are as follows:

• Adults: Treat the affected patches of the skin 1-3 times a day.
• Children: Frequency of use and dosage must be provided by a healthcare expert.

The following recommendations on the application of Betnovate should be discussed with your attending physician.

1. The preparation is designed as a topical agent. Make sure it does not get into your eyes.
2. Disperse this medicine thinly all over the affected skin patches. Massage it in carefully.
3. Avoid using cosmetics and other products for skin care on the treated patches.
4. Do not place bandaging material or wraps on the treated skin patches unless specifically instructed to do so by a medical expert.
5. If the preparation is put on an infant’s diaper area, choose diapers that do not fit tightly and avoid using plastic pants except when this complies with your doctor’s instructions.

Safety information

This medication may contain benzyl alcohol. It is, therefore, contraindicated in newborn children. The medicine may lead to severe and even fatal nervous system issues in infants.

Corticosteroids could impact the growth rate in little children and, in certain cases, adolescents. These categories of patients may require systematic growth checks while staying on the treatment.

Betnovate poses unknown risks in children populations; its safety in patients under 16 years of age have not been sufficiently studied.

Cases of pregnancy need to be monitored by a doctor. Pregnant women should discuss the possible benefits and hazards of using the remedy with their primary care physician. This remedy can pass in breast milk. Nursing mothers need to see a medical expert before starting the treatment.

Side effects

Sudden discontinuation of Betnovate may cause signs of withdrawal. These symptoms may manifest as a hormonal disbalance (in both male and female patients).

Most topical agents may cause adverse events ranging from mild to troubling or even dangerous (e.g. allergic reactions).

Watch your state closely and seek medical help if any of the side effects provided below become persistently unpleasant:

Pimples, clumsiness, giddiness, redness of the face, discomforting sensations in the body, headaches, strong appetite, strong perspiration, unsteadiness, nausea, agitation, trouble sleeping, stomachache.